Knight R G, Harrison A
N Z Med J. 1979 Apr 25;89(634):302-4.
Thirty chronic schizophrenic patients participated in a double-blind crossover trial of thiothixene (Navane) and a control drug combination of trifluoperazine and chlorpromazine. No statistically significant difference was found between the two drug conditions on numerous behavioural scales. Experience with thiothixene suggested that it was comparable with control drugs in the activation of withdrawn patients but needs to be used in combination with a more sedative antipsychotic agent in the treatment of some paranoid patients.
30名慢性精神分裂症患者参与了硫利达嗪(甲硫达嗪)与三氟拉嗪和氯丙嗪对照药物组合的双盲交叉试验。在众多行为量表上,两种药物状况之间未发现统计学上的显著差异。硫利达嗪的使用经验表明,在激活退缩患者方面它与对照药物相当,但在治疗一些偏执型患者时需要与更具镇静作用的抗精神病药物联合使用。